In contrast to the abundancy of inflammatory infiltrates observed in the lesions of the anti-CCL5-treated animals, such responses were rather poor wihin liver tumors of other treated mice, suggesting that CCL5 blockade may favour immune destruction of the tumor. The gene discussed is CCL5; the disease is neoplasm.